Blue Cap AG operates in the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Blue Cap AG with three other
financial institutions in Europe:
HBM Healthcare Investments AG
sales of 235.06 million Swiss Francs [US$255.77 million]
Aforti Holding SA
(1.01 billion Polish New Zlotys [US$265.83 million]
BB Biotech AG
based in SWITZERLAND
(280.93 million Swiss Francs [US$305.69 million]
of which 100%
was Investing & Related Activity).
Blue Cap AG reported sales of 258.91 million Euro (US$308.59 million)
December of 2020.
increase of 11.3%
versus 2019, when the company's sales were 232.55 million Euro.
Sales at Blue Cap AG have increased during each of the previous five years
(and since 2015, sales have increased a total of 221%).
Sales of Other Services saw an increase
that was more than double the company's growth rate: sales were up
98.4% in 2020, from
4.74 million Euro to 9.40 million Euro.
Blue Cap AG also saw significant increases in sales in
Plastics Technology (up 38.4% to 100.72 million Euro)
Metal Technology (up 37.4% to 31.82 million Euro)
Not all segments of Blue Cap AG experienced an increase in sales in 2020:
sales of Production Technology fell 50.7% to 10.64 million Euro.
Blue Cap AG also experienced decreases in sales in
Coating Technology (down 12.5% to 54.48 million Euro)
Adhesives (down 13.8% to 30.75 million Euro)